153 related articles for article (PubMed ID: 10420599)
1. Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography.
Floridi A; Trizza V; Paolotti P; Lucarelli C
J Chromatogr A; 1999 Jun; 846(1-2):65-71. PubMed ID: 10420599
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
[TBL] [Abstract][Full Text] [Related]
3. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
Miyazaki K; Nagai R; Horiuchi S
J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
[TBL] [Abstract][Full Text] [Related]
5. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
[TBL] [Abstract][Full Text] [Related]
6. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection.
Scheijen JL; van de Waarenburg MP; Stehouwer CD; Schalkwijk CG
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):610-4. PubMed ID: 19188098
[TBL] [Abstract][Full Text] [Related]
7. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.
Odetti P; Fogarty J; Sell DR; Monnier VM
Diabetes; 1992 Feb; 41(2):153-9. PubMed ID: 1733803
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
[TBL] [Abstract][Full Text] [Related]
9. Daily haemodialysis improves indices of protein glycation.
Floridi A; Antolini F; Galli F; Fagugli RM; Floridi E; Buoncristiani U
Nephrol Dial Transplant; 2002 May; 17(5):871-8. PubMed ID: 11981076
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis techniques and advanced glycation end products.
Tessitore N; Lapolla A; Aricó CN; Gammaro L; Bernich P; Fedele D
Contrib Nephrol; 2001; (131):33-9. PubMed ID: 11125561
[No Abstract] [Full Text] [Related]
11. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
[TBL] [Abstract][Full Text] [Related]
13. A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma.
Słowik-Zyłka D; Safranow K; Dziedziejko V; Bukowska H; Ciechanowski K; Chlubek D
J Biochem Biophys Methods; 2004 Nov; 61(3):313-29. PubMed ID: 15571779
[TBL] [Abstract][Full Text] [Related]
14. ELISA of pentosidine, an advanced glycation end product, in biological specimens.
Taneda S; Monnier VM
Clin Chem; 1994 Sep; 40(9):1766-73. PubMed ID: 8070089
[TBL] [Abstract][Full Text] [Related]
15. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
[TBL] [Abstract][Full Text] [Related]
16. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
[TBL] [Abstract][Full Text] [Related]
17. A sensitive and specific ELISA for plasma pentosidine.
Izuhara Y; Miyata T; Ueda Y; Suzuki D; Asahi K; Inagi R; Sakai H; Kurokawa K
Nephrol Dial Transplant; 1999 Mar; 14(3):576-80. PubMed ID: 10193802
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.
Miyata T; Ueda Y; Shinzato T; Iida Y; Tanaka S; Kurokawa K; van Ypersele de Strihou C; Maeda K
J Am Soc Nephrol; 1996 Aug; 7(8):1198-206. PubMed ID: 8866413
[TBL] [Abstract][Full Text] [Related]
19. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of furosine and pentosidine in CAPD patients.
Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]